SCHEMBL19959804

SCHEMBL19959804

O=P(c1cccnc1)(c1ccc2ccccc2c1)c1ccc2c3ccccc3n3c4ccccc4nc3c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.38
ALDH1A1 P00352 5/20 0.35
KMT2A Q03164 5/20 0.35
MEN1 O00255 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
MAPT P10636 5/20 0.34
KDM4E B2RXH2 4/20 0.34
POLB P06746 2/20 0.34
LMNA P02545 2/20 0.34
TP53 P04637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HPGD P15428 3/20 0.34
BCL2 P10415 1/20 0.33
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 1/20 0.32
CASP1 P29466 1/20 0.32
CYP2C19 P33261 1/20 0.32
CASP7 P55210 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19959809 0.97 CYP2C9 (0.38) CYP2C9ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL19959848 0.93 KDM4E (0.39) CYP2C9ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL19959790 0.93 SMN1; SMN2 (0.37) CYP2C9ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL19959784 0.92 CYP2C9 (0.37) CYP2C9ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL19928995 0.91 KDM4E (0.41) CYP2C9ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL19959854 0.90 KDM4E (0.40) CYP2C9ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL19959803 0.90 KDM4E (0.41) CYP2C9ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL19959808 0.89 MAPT (0.35) CYP2C9ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL19959886 0.88 KDM4E (0.39) CYP2C9ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL19960169 0.88 KDM4E (0.33) CYP2C9ALDH1A1KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 CYP2C9 143/4885ALDH1A1 750/4885KMT2A 443/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 CYP2C9 143/4885ALDH1A1 750/4885KMT2A 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.